Your browser doesn't support javascript.
loading
HIV MDR is still a relevant issue despite its dramatic drop over the years.
Armenia, D; Di Carlo, D; Flandre, P; Bouba, Y; Borghi, V; Forbici, F; Bertoli, A; Gori, C; Fabeni, L; Gennari, W; Pinnetti, C; Mondi, A; Cicalini, S; Gagliardini, R; Vergori, A; Bellagamba, R; Malagnino, V; Montella, F; Colafigli, M; Latini, A; Marocco, R; Licthner, M; Andreoni, M; Mussini, C; Ceccherini-Silberstein, F; Antinori, A; Perno, C F; Santoro, M M.
Affiliation
  • Armenia D; UniCamillus International University of Health and Medical Sciences, Rome, Italy.
  • Di Carlo D; University of Rome 'Tor Vergata', Department of Experimental Medicine, Rome, Italy.
  • Flandre P; University of Milan, Pediatric Clinical Research Center 'Romeo and Enrica Invernizzi', Milan, Italy.
  • Bouba Y; INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP) équipe Epidémiologie clinique des maladies virales chroniques, Paris, France.
  • Borghi V; University of Rome 'Tor Vergata', Department of Experimental Medicine, Rome, Italy.
  • Forbici F; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon.
  • Bertoli A; Clinic of Infectious Diseases, University Hospital, University of Modena and Reggio Emilia, Modena, Italy.
  • Gori C; Laboratory of Virology, National Institute for Infectious Diseases 'Lazzaro Spallanzani', IRCCS, Rome, Italy.
  • Fabeni L; University of Rome 'Tor Vergata', Department of Experimental Medicine, Rome, Italy.
  • Gennari W; Laboratory of Virology, National Institute for Infectious Diseases 'Lazzaro Spallanzani', IRCCS, Rome, Italy.
  • Pinnetti C; University of Rome 'Tor Vergata', Department of Experimental Medicine, Rome, Italy.
  • Mondi A; Microbiology Unit, University Hospital of Modena, Modena, Italy.
  • Cicalini S; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Gagliardini R; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Vergori A; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Bellagamba R; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Malagnino V; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Montella F; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
  • Colafigli M; Clinical Infectious Diseases, University Hospital 'Tor Vergata', Rome, Italy.
  • Latini A; Infectious disease Unit, San Giovanni Addolorata Hospital, Rome, Italy.
  • Marocco R; Unit of Dermatology and Sexually Transmitted Diseases, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Licthner M; Unit of Dermatology and Sexually Transmitted Diseases, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  • Andreoni M; Infectious Diseases Unit, 'Sapienza' University, Polo Pontino, Latina, Italy.
  • Mussini C; Infectious Diseases Unit, 'Sapienza' University, Polo Pontino, Latina, Italy.
  • Ceccherini-Silberstein F; Clinical Infectious Diseases, University Hospital 'Tor Vergata', Rome, Italy.
  • Antinori A; Clinic of Infectious Diseases, University Hospital, University of Modena and Reggio Emilia, Modena, Italy.
  • Perno CF; University of Rome 'Tor Vergata', Department of Experimental Medicine, Rome, Italy.
  • Santoro MM; HIV/AIDS Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
J Antimicrob Chemother ; 75(5): 1301-1310, 2020 05 01.
Article in En | MEDLINE | ID: mdl-31976521

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Antimicrob Chemother Year: 2020 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Antimicrob Chemother Year: 2020 Document type: Article Affiliation country: Italy Country of publication: United kingdom